NVOS Stock Price Target: 2026 Forecast & Analysis
Type “NVOS stock price target” into Google and you will hit a wall of contradictions. One site predicts the stock climbing past $2. Another shows it falling toward zero. A third simply says “N/A.” All three can be technically accurate at the same time, and that tells you almost everything you need to know about this stock before you look at a single chart.
Novo Integrated Sciences (NVOS) is not a company with a normal analyst-covered price target. It’s a micro-cap that got knocked off Nasdaq and now trades for a fraction of a cent on the OTC market. Any “target” you find online is either a Wall Street placeholder, an algorithm’s guess, or a trader’s opinion on a message board. This guide walks through what’s really out there, what it means, and how to read it without getting misled.
What Is NVOS Stock, Exactly?
Novo Integrated Sciences is a Bellevue, Washington-based company built around multidisciplinary healthcare services and related product sales, with operations tied to primary care and wellness offerings in Canada. It has changed shape several times over the past few years through acquisitions, subsidiary consulting deals, and financing agreements, which is part of why the stock has been so hard to pin down.
If you want the fuller company history, including its past pivots and business segments, the site’s comprehensive overview of Novo Integrated Sciences walks through where the business has been and how it got here. It’s worth reading before you look at any price prediction, because the stock’s story matters more than the chart does at this point.
Does NVOS Have a Real Analyst Price Target?
Short answer: not in the way most stocks do.
A traditional “price target” comes from licensed equity analysts at brokerage firms who model a company’s earnings, cash flow, and growth, then publish a 12-month target price. Large caps like Apple or Novo Nordisk have dozens of analysts doing this. NVOS does not. Coverage pages on Nasdaq, MarketBeat, and TipRanks routinely list its price target and consensus rating as “N/A” because no major bank or research desk actively covers the stock anymore.
What you’ll find instead are algorithmic forecasts from sites like StockScan, WalletInvestor, and Gov.Capital. These use statistical models, momentum, and pattern recognition rather than fundamentals or analyst judgment. They’re not the same thing as a Wall Street price target, and they should be treated with a healthy amount of skepticism, especially for a stock this thinly traded and this cheap.
NVOS Stock Price Target: Forecast Comparison Table
Here’s how a few of the most-cited forecasting tools stack up. These numbers change constantly and vary wildly between sources, which is itself the main takeaway.
| Source | Forecast Type | Price Target Range | Notes |
| StockScan (30-day) | Algorithmic | ~$2.05 – $2.07 | Extrapolated from technical indicators, not analyst research |
| StockScan (2026 average) | Algorithmic | ~$1.07 – $2.22 | Assumes a sharp reversal from current sub-cent levels |
| WalletInvestor | Algorithmic | Roughly flat to lower long-term | Long-standing bearish bias on this ticker |
| Gov.Capital | Deep-learning model | Near-zero within 12 months | One of the more bearish algorithmic reads |
| One of the more bearish algorithmic reads | Institutional analyst consensus | N/A | No active analyst coverage on record |
Two things stand out here. First, the algorithmic sites disagree with each other by orders of magnitude, sometimes projecting gains in the tens of thousands of percent from the current price, which is a strong sign the model is reacting to a rounding effect on a stock trading in fractions of a cent rather than producing a meaningful forecast. Second, the only category with genuine research behind it, licensed analyst coverage, simply isn’t available for this stock right now, visit more.
For a deeper breakdown of the 2026 outlook specifically, the site’s NVOS stock forecast page covers price scenarios, risk factors, and what would need to change for the stock to see sustained upside.
Why NVOS Trades for Fractions of a Cent
NVOS wasn’t always a sub-penny stock. It was delisted from the Nasdaq Capital Market in late 2024 after failing to maintain the exchange’s minimum bid price requirement, and it has traded on the OTC market since. Before that, the company carried out a 1-for-10 reverse split in November 2023, an attempt to lift the share price back above listing thresholds.
Reverse splits reduce the share count and multiply the price per share, but they don’t add value to the company. If dilution and financing needs continue afterward, as they have here through various securities purchase agreements, the price tends to drift back down. For the full history of NVOS’s share structure changes and what a future reverse split could mean for existing holders, see the NVOS reverse split breakdown.
This history is the real backdrop behind every price target you’ll see quoted. A model predicting a jump from $0.003 to $2 isn’t describing organic growth; it’s describing what would have to happen after another major restructuring, a new listing attempt, or a shift in the underlying business.
What Could Actually Move NVOS Higher
A few realistic catalysts show up again and again in coverage of this stock:
- A capital raise or debt restructuring that stabilizes the balance sheet enough to support renewed investor interest.
- A relisting attempt on a major exchange, which would likely require another reverse split and a much higher qualifying price.
- New contracts or partnerships tied to its healthcare services or consulting subsidiaries.
- A short-term speculative squeeze, common in low-float penny stocks when retail trading volume spikes.
None of these are guaranteed, and several depend on financing terms that could dilute existing shareholders further even if the stock price rises in the short run.
What Could Keep the Price Target Low
On the other side of the ledger:
- Continued share dilution from securities purchase agreements and similar financing.
- Weak or delayed financial reporting, which has been a recurring issue for the company.
- Thin trading volume, which makes the stock more volatile and harder to exit in size.
- No path back to a major exchange in the near term, which limits the pool of investors willing to hold it.
How to Track NVOS Price Action and Sentiment
Because formal analyst coverage is missing, a lot of NVOS-focused investors lean on retail sentiment instead, watching what other traders are saying in real time rather than waiting on a research note that may never come. Two good places to see that in practice are the NVOS Stocktwits sentiment breakdown and the ongoing look at what NVOS traders are discussing, both of which track the chatter that tends to move this kind of low-float stock in the short term.
Sentiment tracking isn’t a substitute for fundamentals, but for a stock with no analyst coverage, it’s often the fastest read on what’s driving day-to-day price swings.
Is NVOS Worth Buying at Current Levels?
That’s not a question anyone can answer for you, and this article isn’t financial advice. What can be said plainly: NVOS carries the risk profile of a distressed micro-cap. It has no analyst price target because no analysts are covering it, its share price reflects a delisting and a prior reverse split, and the “targets” circulating online come from automated models with a track record of disagreeing wildly with each other on this exact ticker.
If you’re considering a position, treat every price prediction you read, including the ones in the table above, as a rough scenario rather than a forecast you can rely on. Look at the company’s actual filings, its cash position, and its financing history before you look at any target price.
FAQs
Does NVOS stock have an official analyst price target?
No. As of the most recent data from Nasdaq, MarketBeat, and TipRanks, NVOS has no active analyst coverage, so there’s no consensus price target from licensed research firms.
Why do some sites show NVOS reaching $1 or $2?
Those numbers come from algorithmic forecasting tools, not analyst research. They model technical patterns and momentum, and for a stock trading in fractions of a cent, small dollar moves translate into enormous percentage swings, which can make the projections look more dramatic than they are.
Is NVOS still listed on Nasdaq?
No. NVOS was delisted from the Nasdaq Capital Market in late 2024 after failing to meet the minimum bid price requirement and now trades on the OTC market.
Did NVOS do a reverse stock split?
Yes, a 1-for-10 reverse split took effect in November 2023. You can read the full history and ratio details on the site’s reverse split page.
Where can I check real-time sentiment on NVOS?
Retail trading platforms and Stocktwits threads are the most common places, since there’s no analyst commentary to follow. The NVOS Stocktwits coverage tracks what traders are currently saying.
Is NVOS a good long-term investment?
That depends entirely on your own risk tolerance and research. NVOS carries the risks typical of a delisted, thinly traded penny stock, including dilution and limited financial transparency. This article is informational only and isn’t investment advice.
Conclusion
The honest answer to “what’s the NVOS stock price target” is that there isn’t a reliable one right now. No major analyst desk covers the stock, and the algorithmic forecasts that fill the search results disagree with each other by huge margins, mostly because they’re reacting to a sub-penny share price rather than the company’s actual fundamentals.
If you’re researching NVOS, spend more time understanding why it delisted and how its share structure got here than chasing a specific target number. That context will tell you more than any forecast tool will.





